Research Article
Association between Clinical Characteristics and Laboratory Findings with Outcome of Hospitalized COVID-19 Patients: A Report from Northeast Iran
Table 2
Baseline clinical manifestations and laboratory findings of survivors and nonsurvivors of COVID-19.
| | | Total (n = 397) | Survivors (n = 336) | Nonsurvivors (n = 61) | value |
| | Fever (%) | 225 (56.7) | 189 (56.3) | 32 (52.4) | 0.573 | | Headache (%) | 59 (14.9) | 56 (16.7) | 3 (5) | 0.017 | | Sore throat (%) | 43 (10.8) | 36 (10.7) | 7 (11.4) | 0.825 | | Chest pain (%) | 56 (14.1) | 51 (15.2) | 5 (8.2) | 0.166 | | Myalgia (%) | 126 (31.7) | 110 (32.7) | 16 (26.2) | 0.369 | | Smell disorder (%) | 29 (7.3) | 27 (8) | 2 (3.3) | 0.284 | | Taste disorder (%) | 24 (6) | 22 (6.5) | 2 (3.3) | 0.557 | | Pharyngeal exudates (%) | 7 (1.8) | 6 (1.8) | 1 (1.6) | 0.431 | | Decreased consciousness (%) | 8 (2) | 3 (0.9) | 5 (8.2) | 0.003 | | Dyspnea (%) | 74 (18.6) | 55 (16.4) | 19 (31.1) | 0.011 | | Chest tightness (%) | 261 (65.7) | 211 (62.8) | 43 (70.5) | 0.303 | | Nausea and vomiting (%) | 99 (24.9) | 87 (25.9) | 11 (18) | 0.200 | | Diarrhea (%) | 51 (12.8) | 46 (13.7) | 5 (8.2) | 0.300 | | Initial WBC (103/mm3) | 8.80 ± 5.29 | 8.25 ± 4.51 | 11.67 ± 7.67 | <0.001 | | Initial CRP (μg/dL) | 90.13 ± 77.73 | 78.86 ± 66.80 | 140.94 ± 100.92 | <0.001 | | Initial ESR (mm/h) | 51.55 ± 32.46 | 50.34 ± 32.51 | 57.03 ± 32.03 | <0.001 |
|
|
Data are presented as % and means ± SDs. WBC: white blood cells; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate.
|
